Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,380,800 | 2,694,500 | 3,545,900 | 2,067,000 | 2,617,400 |
| Marketable Securities | 113,100 | 134,600 | 123,400 | 144,800 | 124,700 |
| Receivables | 10,363,800 | 9,171,400 | 9,022,101 | 8,558,900 | 8,324,800 |
| Inventories | 4,901,400 | 4,798,700 | 4,544,800 | 4,309,700 | 3,831,100 |
| Other current assets | 0 | 0 | -1 | 7,300 | 0 |
| TOTAL | $23,007,000 | $21,331,600 | $20,811,400 | $18,034,500 | $17,639,900 |
| Non-Current Assets | |||||
| PPE Net | 11,863,200 | 11,277,400 | 10,546,200 | 10,144,000 | 9,311,300 |
| Investments And Advances | 2,691,700 | 2,745,100 | 2,750,400 | 2,901,800 | 2,574,600 |
| Intangibles | 6,781,700 | 6,903,500 | 7,087,100 | 7,206,600 | 7,124,100 |
| Other Non-Current Assets | 13,571,900 | 12,556,400 | 11,967,900 | 11,202,900 | 10,811,600 |
| TOTAL | $34,908,500 | $33,482,400 | $32,351,600 | $31,455,300 | $29,821,600 |
| Total Assets | $57,915,500 | $54,814,000 | $53,163,000 | $49,489,800 | $47,461,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,435,100 | 2,474,200 | 2,015,900 | 1,930,600 | 1,683,200 |
| Other current liabilities | 15,340,900 | 13,529,200 | 12,462,700 | 12,689,300 | 11,539,400 |
| TOTAL | $21,998,200 | $18,915,000 | $16,010,000 | $17,138,200 | $15,652,800 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,923,600 | 18,158,400 | 18,880,500 | 14,737,500 | 14,143,800 |
| Other Non-Current Liabilities | 6,686,300 | 6,591,300 | 6,977,600 | 6,838,700 | 7,327,100 |
| TOTAL | $24,609,900 | $24,749,700 | $25,858,100 | $21,576,200 | $21,642,800 |
| Total Liabilities | $46,608,100 | $43,664,700 | $41,868,100 | $38,714,400 | $37,295,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 949,307 | 949,295 | 949,273 | 950,296 | 950,178 |
| Common Shares | 593,600 | 593,600 | 593,500 | 594,100 | 594,100 |
| Retained earnings | 10,309,900 | 10,368,500 | 10,639,300 | 10,042,600 | 10,006,500 |
| Other shareholders' equity | -6,711,100 | -6,716,400 | -6,686,000 | -6,731,700 | -7,212,700 |
| TOTAL | $11,307,400 | $11,149,300 | $11,294,900 | $10,775,400 | $10,165,900 |
| Total Liabilities And Equity | $57,915,500 | $54,814,000 | $53,163,000 | $49,489,800 | $47,461,500 |